New Research Fails To Support The Use Of An Anti-Psychotic Drug (Aripiprazole) For Depression
In the current issue of Psychotherapy and Psychosomatics, researchers failed to find evidence for the use of aripiprazole (Abilify®) in depression. In this study the investigators assessed the efficacy of low-dose aripiprazole added to antidepressant therapy (ADT) in patients with major depressive disorder (MDD) with inadequate response to prior ADT. ...
Read more ›